158 related articles for article (PubMed ID: 29700339)
21. Identification of genomic mutations associated with clinical outcomes of induction chemotherapy in patients with head and neck squamous cell carcinoma.
Ock CY; Son B; Keam B; Lee SY; Moon J; Kwak H; Kim S; Kim TM; Jeon YK; Kwon SK; Hah JH; Lee SH; Kwon TK; Kim DW; Wu HG; Sung MW; Heo DS
J Cancer Res Clin Oncol; 2016 Apr; 142(4):873-83. PubMed ID: 26677030
[TBL] [Abstract][Full Text] [Related]
22. DIRC3 and near NABP1 genetic polymorphisms are associated laryngeal squamous cell carcinoma patient survival.
Shen Z; Ren W; Bai Y; Chen Z; Li J; Li B; Jin T; Cao P; Shao Y
Oncotarget; 2016 Nov; 7(48):79596-79604. PubMed ID: 27793000
[TBL] [Abstract][Full Text] [Related]
23. Interest of next-generation sequencing in BCG-treated high-risk bladder cancer.
Jungels C; Martinez Chanza N; Albisinni S; Mercier M; d'Haene N; Rorive S; Roumeguère T
Prog Urol; 2018 May; 28(6):344-350. PubMed ID: 29673906
[TBL] [Abstract][Full Text] [Related]
24. Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma.
Chau NG; Li YY; Jo VY; Rabinowits G; Lorch JH; Tishler RB; Margalit DN; Schoenfeld JD; Annino DJ; Goguen LA; Thomas T; Becker H; Haddad T; Krane JF; Lindeman NI; Shapiro GI; Haddad RI; Hammerman PS
Clin Cancer Res; 2016 Jun; 22(12):2939-49. PubMed ID: 26763254
[TBL] [Abstract][Full Text] [Related]
25. The degree of intratumor mutational heterogeneity varies by primary tumor sub-site.
Ledgerwood LG; Kumar D; Eterovic AK; Wick J; Chen K; Zhao H; Tazi L; Manna P; Kerley S; Joshi R; Wang L; Chiosea SI; Garnett JD; Tsue TT; Chien J; Mills GB; Grandis JR; Thomas SM
Oncotarget; 2016 May; 7(19):27185-98. PubMed ID: 27034009
[TBL] [Abstract][Full Text] [Related]
26. Mutations in the D-loop region and increased copy number of mitochondrial DNA in human laryngeal squamous cell carcinoma.
Guo W; Yang D; Xu H; Zhang Y; Huang J; Yang Z; Chen X; Huang Z
Mol Biol Rep; 2013 Jan; 40(1):13-20. PubMed ID: 23114912
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
[TBL] [Abstract][Full Text] [Related]
28. Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer.
Christensen E; Birkenkamp-Demtröder K; Nordentoft I; Høyer S; van der Keur K; van Kessel K; Zwarthoff E; Agerbæk M; Ørntoft TF; Jensen JB; Dyrskjøt L
Eur Urol; 2017 Jun; 71(6):961-969. PubMed ID: 28069289
[TBL] [Abstract][Full Text] [Related]
29. Mutually exclusive mutations in NOTCH1 and PIK3CA associated with clinical prognosis and chemotherapy responses of esophageal squamous cell carcinoma in China.
Song B; Cui H; Li Y; Cheng C; Yang B; Wang F; Kong P; Li H; Zhang L; Jia Z; Bi Y; Wang J; Zhou Y; Liu J; Wang J; Zhao Z; Zhang Y; Hu X; Shi R; Yang J; Liu H; Yan T; Li Y; Xu E; Qian Y; Xi Y; Guo S; Chen Y; Wang J; Li G; Liang J; Jia J; Chen X; Guo J; Wang T; Zhang Y; Li Q; Wang C; Cheng X; Zhan Q; Cui Y
Oncotarget; 2016 Jan; 7(3):3599-613. PubMed ID: 26528858
[TBL] [Abstract][Full Text] [Related]
30. Full-length spleen tyrosine kinase inhibits the invasion and metastasis of human laryngeal squamous cell carcinoma.
Li Z; Cai Z; Tao B; Jin Q
Int J Clin Exp Pathol; 2015; 8(12):15786-93. PubMed ID: 26884848
[TBL] [Abstract][Full Text] [Related]
31. Detection of C-MYC oncogene translocation and copy number change in the normal-dysplasia-carcinoma sequence of the larynx by fluorescence in situ hybridization.
Liu Y; Gong LP; Dong XL; Liu HG
Diagn Cytopathol; 2013 Jun; 41(6):515-9. PubMed ID: 22715132
[TBL] [Abstract][Full Text] [Related]
32. Inter- and intra-tumor profiling of multi-regional colon cancer and metastasis.
Kogita A; Yoshioka Y; Sakai K; Togashi Y; Sogabe S; Nakai T; Okuno K; Nishio K
Biochem Biophys Res Commun; 2015 Feb; 458(1):52-6. PubMed ID: 25623536
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive mutation profiling by next-generation sequencing of effusion fluids from patients with high-grade serous ovarian carcinoma.
Shah RH; Scott SN; Brannon AR; Levine DA; Lin O; Berger MF
Cancer Cytopathol; 2015 May; 123(5):289-97. PubMed ID: 25655233
[TBL] [Abstract][Full Text] [Related]
34. Targeted next-generation sequencing of 50 cancer-related genes in Japanese patients with oral squamous cell carcinoma.
Nakagaki T; Tamura M; Kobashi K; Omori A; Koyama R; Idogawa M; Ogi K; Hiratsuka H; Tokino T; Sasaki Y
Tumour Biol; 2018 Sep; 40(9):1010428318800180. PubMed ID: 30226113
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of p53 nuclear protein in premalignant and malignant laryngeal lesions.
Nakashima T; Wang XF; Masuda M; Inokuchi A; Komiyama S
Eur Arch Otorhinolaryngol; 1999; 256 Suppl 1():S56-9. PubMed ID: 10337529
[TBL] [Abstract][Full Text] [Related]
36. Zinc finger protein x-linked (ZFX) contributes to patient prognosis, cell proliferation and apoptosis in human laryngeal squamous cell carcinoma.
Yang F; Ma H; Feng L; Lian M; Wang R; Fan E; Fang J
Int J Clin Exp Pathol; 2015; 8(11):13886-99. PubMed ID: 26823701
[TBL] [Abstract][Full Text] [Related]
37. Mutation Yield of a 34-Gene Solid Tumor Panel in Community-Based Tumor Samples.
Sanders H; Qu K; Li H; Ma L; Barlan C; Zhang X; Prentice J; Wolfson D; Crossley B; Sferruzza A; Sninsky J; Ross D; Grupe A; Catanese J; Hantash F; Waldman F
Mol Diagn Ther; 2016 Jun; 20(3):241-53. PubMed ID: 27084556
[TBL] [Abstract][Full Text] [Related]
38. SSTR2 promoter hypermethylation is associated with the risk and progression of laryngeal squamous cell carcinoma in males.
Shen Z; Chen X; Li Q; Zhou C; Li J; Ye H; Duan S
Diagn Pathol; 2016 Jan; 11():10. PubMed ID: 26796520
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of thrombospondin-1 by DNA hypermethylation is associated with tumor progression in laryngeal squamous cell carcinoma.
Huang C; Zhou X; Li Z; Liu H; He Y; Ye G; Huang K
Mol Med Rep; 2016 Sep; 14(3):2489-96. PubMed ID: 27485791
[TBL] [Abstract][Full Text] [Related]
40. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
